Seraphim Holdings
Date of Foundation
2011

Seraphim Holdings

Innovative BioTech and Regenerative Medicine Pioneer

The Idea origin story

Aim to become the foremost venture tech firm, leading innovations in Biotech and cutting-edge therapeutics. Personalize healthcare through a multifaceted approach combining regenerative medicine with patient-specific customization. Utilize technologies such as Data Science, Artificial Intelligence, and Big Data along with traditional healing wisdom applied innovatively for breakthrough medical solutions.

The Mission

"Revolutionizing healthcare through personalized bio-tech solutions, leveraging AI and ancestral wisdom for therapeutic breakthroughs."

Clients

Investors, Cosmetics industry, Nutraceuticals industry, CBD industry, Green Energy, BioMarkers Industry, Pharmaceutical Industry, Consumers, Retail, White Label, Wholesale,

Problems we solve

Client’s problem

Your startup can solve problems in personalized healthcare, enhance the development and delivery of regenerative medicine, and bring innovative biotech solutions to various industries like cosmetics, pharmaceuticals, and green energy.

Confirmation of problem

current therapies often fall short in safety and efficacy, prompting the need for better disease management strategies and regenerative medicine.

Solution

To become a unicorn startup, firstly, you need to define your vision clearly. Focus on how your product can solve an existing need or problem

Our technologies

This solution is based on technologies

Nutraceuticals, AI, data driven technologies, Stem Cells, Exosomes, Peptides, state of the art formulation capabilities, Biomarkers,

How it works

Your inquiry encompasses a wide range of aspects.

Value for the client

Enhancing global wellness insight and health mechanisms. Innovating targeted therapies for new healthcare paradigm shift.

Market and strategy

Market size

20000

mln/year

We estimate the market size for which our solution is designed in monetary terms as follows

Market share goal

2

% of the market

Is our goal in the next 3 years

Team

My name’s

Blake Staring

My key role in the product

My key role is a Co-Founder, and I'm responsible for raising capital, marketing strategies, sales, strategic partnerships and fundraising.

Team size and key members

Co-Founder Joe Trygar, a global leader in health analytics and automation, manages R&D and strategic partnerships.

Competitors

Competitors

Your startup operates in BioTech, with a focus on therapeutics and regenerative medicine. Thus, your competitors can be large pharmaceutical companies advancing in this field as well as emerging biotech startups working on similar innovations. Also, consider health and wellness brands expanding into the biotech sphere or providing alternative therapies that might compete with your offerings. Always keep an eye on advancements from scientific & tech sectors as they may produce unexpected competition. It's crucial to distinctively position yourselves and constantly innovate while ensuring excellent user

Our Advantages

Our products pave the way for preventative medicine. Leveraging specific formulations and regenerative therapies, we focus on enhancing lifespan. Our proactive approach prioritizes prevention, crafting personalized treatment strategies for improved health outcomes.

Business model

Our income comes from supplying wellness products to a variety of sectors including health, beauty and retail stakeholders.

Traction

Product progression is in its initial phase. This startup aims to transform ideas into actions, cultivating raw concepts into a viable product that signifies an explosive blend of innovation and potential.

From inception to reality, our company has flourished. Our innovation-centric culture propels us forward in a relentless pursuit of success, striving for growth and setting the stage for becoming a potential unicorn startup.

Metrics

Product metrics are key performance indicators that track the success and growth of your startup's product. Analyzing these can help refine strategies, improve user experience, and increase overall business profitability. Monitor customer usage patterns for effective decision-making.

Incorporation

Our company incorporated in

Delaware

Key risks

Major risks could include regulatory issues, unpredictable medical trial outcomes, rapid technological developments outdating your products or methods, intense competition in the biotech sector and dependence on investor funding. Lack of market acceptance for new therapies could also pose a risk.

Investments

$

0

We raised investments

Our Investors

Venture Capitalists

Rising Investments

$

1500000

Currently, we are raising investments

$

12000000

Estimated pre-investment valuation of the company

We’re looking for a co-founders

Open positions

Article

Read

Additional information

MVP